Monoclonal Antibody Therapeutics Market
According to Intent Market Research, the Monoclonal Antibody Therapeutics Market is expected to grow from USD 78.6 Billion in 2024-e at a CAGR of 7.2% to touch USD 127.6 Billion by 2030. The Monoclonal Antibody Therapeutics Market is dominated by key players such as, Roche, Merck & Co., Johnson & Johnson, AbbVie, Amgen, and Bristol-Myers Squibb